Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials

Multiple Sclerosis Journal - Experimental, Translational and Clinical
doi 10.1177/2055217318778610